top of page
2025 Buddhism, BioEngineering & Life
6th Woodenfish Forum on Buddhism, Science and Future
Date: June 25-27
Venue: Grand Hotel, Taipei, Taiwan
6th Woodenfish Buddhism Science & Future
2025 Theme: Buddhism, BioEngineering and BioLife
Potential panels:
Panel 1: AI, Consciousness, and Biotechnology
Panel 2: Synthetic Embryos, Conception and Dependent Origination
Panel 3: Bioengineering, Genes and Karma
Panel 4: Motherhood, Abortion, and Ethics
Panel 5: Future challenges for Buddhism & Bioethics
Theme: Buddhism, BioEngineering and BioLife (BBB)
Potential panels:
Panel 1: AI, Consciousness, and Biotechnology
Overview: This panel builds off of the discussions from BSF 2024, Buddhism, Consciousness, and AI, to think about AI developments and their implications in conversation with Buddhism specifically in the context of biotechnology.
Panel 2: Synthetic Embryos, Conception and Dependent Origination
Overview: This panel aims to discuss Buddhist understandings of beginning of life and use Buddhist-based ethics to think about the creation of synthetic embryos in labs as well as IVF.
Panel 3: Bioengineering, Genes and Karma
Overview: This panel aims to think about the implication of other recent developments in bioengineering, such as genetic modification (of both animals and humans), gene therapy, and stem cell modification, for Buddhist conceptions of karma and rebirth and vice versa.
Panel 4: Motherhood, Abortion, and Ethics
Overview: This panel aims to consider the nexus of bioethics and Buddhism from a gendered perspective, thinking about the implications of abortion and surrogacy on motherhood and women, both in and out of Buddhist communities.
Panel 5: Future Challenges for Buddhism and Bioethics
Overview: This panel concludes the conference by considering the ways the issues at the nexus of Buddhism and bioengineering have real life implications and applications for Buddhist practice. In addition, it takes a forward-looking perspective to consider this topic in light of future developments in the field.
第六屆木魚論壇「佛學科學與未來」
2025年主題：”佛學、基因工程與生命科學”
第一場：A I、意識與生物科技
第二場：合成胚胎、受孕與十二因緣
第三場：生物工程、基因與業力
第四場：母職、墮胎與倫理
第五場：未來生物科學對佛學的挑戰
時間：2025年6月25-27日（週三、四、五）
地點：台北圓山大飯店
-集聚世界一流生物科學家與著名佛學學者對話
-開幕與結論由哈佛大學燕京研究所所長James Robson教授主持
場次一：人工智能、意識與生物技術
概述：
本小組討論將在2024年BSF（佛教、意識與人工智能）會議的基礎上，探討人工智能發展的新動向及其影響，尤其是在生物技術領域，與佛教思想的對話中展開討論。
場次二: 合成胚胎、受孕與緣起
概述：
本小組討論旨在探討佛教對生命起源的理解，並運用基於佛教的倫理學思考實驗室中合成胚胎的創造以及試管嬰兒（IVF）技術的發展與應用。
場次三：生物工程、基因與業力
概述：
本小組討論旨在探討生物工程領域的其他最新發展（如動物與人類的基因改造、基因治療以及幹細胞改造）對佛教業力與輪回觀念的影響，以及佛教思想如何反過來對這些技術的發展提供倫理啓示。
場次四：母職、墮胎與倫理
概述：
本小組討論從性別視角出發，探討生物倫理學與佛教思想的交匯點，思考墮胎與代孕對母性及女性的影響，包括佛教社區內外的相關議題。
場次五：佛教與生物倫理的未來挑戰
概述：
本小組討論為大會總結，探討佛教與生物工程交匯處的議題如何對現實生活中的佛教實踐產生影響和應用。同時，以前瞻性的視角審視這一主題，思考未來該領域的發展可能帶來的新挑戰和機遇。
Invited Guest Speakers
依法法師
Venerable Yifa
Founder and Director of the Woodenfish Foundation
木魚基金會創辦人兼主任
Venerable Dr. Yifa is the founder and director of the Woodenfish Foundation, an international, nonsectarian, nonprofit and non-governmental organization that has spent the past twenty years working to establish a global network of ethical and compassionate professionals, scholars, and leaders. She became a nun at Fo Guang Shan Monastery in Taiwan in 1979. She received a law degree from National Taiwan University, a MA in comparative philosophy from University of Hawaii and her Ph.D. in religious studies from Yale University in 1996. She has been the Dean at Fo Guang Shan Buddhist College and the Provost at Hsi Lai University, Rosemead, California, a visiting scholar at the University of California at Berkeley and Harvard University, a lecturer at Boston University and a faculty member at National Sun Yat-Sen University in Taiwan. She taught at McGill University as the Numata visiting professor in the spring of 2005 and served as the chair of the Department of Religious Studies at the University of the West in Los Angeles. She is currently an Associate at the Harvard University Asia Center.
依法法師博士是木魚基金會的創辦人兼主任，該基金會是一個國際性的、無宗派、非營利及非政府組織，致力於建立全球範圍內的道德與慈悲專業人士、學者和領袖網絡，已經有二十年的歷史。她於1979年在台灣佛光山寺出家，並獲得國立台灣大學法學學位，夏威夷大學比較哲學碩士學位，並於1996年獲得耶魯大學宗教研究博士學位。她曾擔任佛光山佛學院院長，並在美國加利福尼亞州的西來大學擔任教務長，曾在加利福尼亞大學柏克萊分校與哈佛大學擔任訪問學者，並曾在波士頓大學擔任講師，以及在台灣國防大學任教。她於2005年春季在麥吉爾大學擔任沼田訪問教授，並曾擔任洛杉磯西方大學宗教學系主任。目前，她是哈佛大學亞洲中心的研究員。
木魚基金會創辦人兼主任
Venerable Dr. Yifa is the founder and director of the Woodenfish Foundation, an international, nonsectarian, nonprofit and non-governmental organization that has spent the past twenty years working to establish a global network of ethical and compassionate professionals, scholars, and leaders. She became a nun at Fo Guang Shan Monastery in Taiwan in 1979. She received a law degree from National Taiwan University, a MA in comparative philosophy from University of Hawaii and her Ph.D. in religious studies from Yale University in 1996. She has been the Dean at Fo Guang Shan Buddhist College and the Provost at Hsi Lai University, Rosemead, California, a visiting scholar at the University of California at Berkeley and Harvard University, a lecturer at Boston University and a faculty member at National Sun Yat-Sen University in Taiwan. She taught at McGill University as the Numata visiting professor in the spring of 2005 and served as the chair of the Department of Religious Studies at the University of the West in Los Angeles. She is currently an Associate at the Harvard University Asia Center.
依法法師博士是木魚基金會的創辦人兼主任，該基金會是一個國際性的、無宗派、非營利及非政府組織，致力於建立全球範圍內的道德與慈悲專業人士、學者和領袖網絡，已經有二十年的歷史。她於1979年在台灣佛光山寺出家，並獲得國立台灣大學法學學位，夏威夷大學比較哲學碩士學位，並於1996年獲得耶魯大學宗教研究博士學位。她曾擔任佛光山佛學院院長，並在美國加利福尼亞州的西來大學擔任教務長，曾在加利福尼亞大學柏克萊分校與哈佛大學擔任訪問學者，並曾在波士頓大學擔任講師，以及在台灣國防大學任教。她於2005年春季在麥吉爾大學擔任沼田訪問教授，並曾擔任洛杉磯西方大學宗教學系主任。目前，她是哈佛大學亞洲中心的研究員。
James Robson
Professor of East Asian Languages and Civilizations at Harvard University and Director of the Harvard-Yenching Institute
哈佛大學東亞語言與文明系教授及哈佛燕京學院主任
James Robson is Professor of East Asian Languages and Civilizations. He has served as Director of Graduate Studies for the Regional Studies East Asia M.A. program. He teaches East Asian religions, in particular Daoism, Chinese Buddhism, and Zen. Robson received his Ph.D. in Buddhist Studies from Stanford University in 2002, after spending many years doing research in China, Taiwan, and Japan. He specializes in the history of medieval Chinese Buddhism and Daoism and is particularly interested in issues of sacred geography, local religious history, talismans, and Chan/Zen Buddhism. He has been engaged in a long-term collaborative research project with the École Française d’Extrême-Orient studying local religious statuary from Hunan province. He is the author of Power of Place: The Religious Landscape of the Southern Sacred Peak [Nanyue 南嶽] in Medieval China (Harvard, 2009), which was awarded the Stanislas Julien Prize for 2010 by the French Academy of Inscriptions and Belles-Lettres and the 2010 Toshihide Numata Book Prize in Buddhism. Robson is also the author of "Signs of Power: Talismanic Writings in Chinese Buddhism" (History of Religions 48:2), "Faith in Museums: On the Confluence of Museums and Religious Sites in Asia" (PMLA, 2010), and "A Tang Dynasty Chan Mummy [roushen] and a Modern Case of Furta Sacra? Investigating the Contested Bones of Shitou Xiqian." His current research includes a long term project on the history of the confluence of Buddhist monasteries and mental hospitals in Japan.
James Robson是哈佛大學東亞語言與文明系教授，曾擔任東亞區域研究碩士課程研究生學位主任。他教授東亞宗教，尤其是道教、中文佛教與禪宗。Robson於2002年獲得斯坦福大學佛教研究博士學位，在此之前，他曾在中國、台灣和日本進行長期研究。他專門研究中國中世紀佛教與道教的歷史，特別關注神聖地理、地方宗教歷史、符咒與禪宗等議題。他目前正在與法國極東學院合作，研究來自湖南省的地方宗教雕像。他是《地方的力量：中世紀中國南嶽的宗教景觀》(哈佛大學出版社，2009年）的作者，該書榮獲2010年法國銘文與美術學院的斯坦尼斯拉斯·朱利安獎與2010年道教南多書獎。Robson還是《力量的跡象：中國佛教中的符咒文字》、《博物館中的信仰：關於亞洲博物館與宗教場所交匯的思考》、以及《唐代禪宗木乃伊[肉身]與現代聖物盜竊案件？調查石頭希遷的爭議骨骸》的作者。他目前的研究項目包括關於日本佛教寺院與精神病院交匯歷史的長期研究計畫。
哈佛大學東亞語言與文明系教授及哈佛燕京學院主任
James Robson is Professor of East Asian Languages and Civilizations. He has served as Director of Graduate Studies for the Regional Studies East Asia M.A. program. He teaches East Asian religions, in particular Daoism, Chinese Buddhism, and Zen. Robson received his Ph.D. in Buddhist Studies from Stanford University in 2002, after spending many years doing research in China, Taiwan, and Japan. He specializes in the history of medieval Chinese Buddhism and Daoism and is particularly interested in issues of sacred geography, local religious history, talismans, and Chan/Zen Buddhism. He has been engaged in a long-term collaborative research project with the École Française d’Extrême-Orient studying local religious statuary from Hunan province. He is the author of Power of Place: The Religious Landscape of the Southern Sacred Peak [Nanyue 南嶽] in Medieval China (Harvard, 2009), which was awarded the Stanislas Julien Prize for 2010 by the French Academy of Inscriptions and Belles-Lettres and the 2010 Toshihide Numata Book Prize in Buddhism. Robson is also the author of "Signs of Power: Talismanic Writings in Chinese Buddhism" (History of Religions 48:2), "Faith in Museums: On the Confluence of Museums and Religious Sites in Asia" (PMLA, 2010), and "A Tang Dynasty Chan Mummy [roushen] and a Modern Case of Furta Sacra? Investigating the Contested Bones of Shitou Xiqian." His current research includes a long term project on the history of the confluence of Buddhist monasteries and mental hospitals in Japan.
James Robson是哈佛大學東亞語言與文明系教授，曾擔任東亞區域研究碩士課程研究生學位主任。他教授東亞宗教，尤其是道教、中文佛教與禪宗。Robson於2002年獲得斯坦福大學佛教研究博士學位，在此之前，他曾在中國、台灣和日本進行長期研究。他專門研究中國中世紀佛教與道教的歷史，特別關注神聖地理、地方宗教歷史、符咒與禪宗等議題。他目前正在與法國極東學院合作，研究來自湖南省的地方宗教雕像。他是《地方的力量：中世紀中國南嶽的宗教景觀》(哈佛大學出版社，2009年）的作者，該書榮獲2010年法國銘文與美術學院的斯坦尼斯拉斯·朱利安獎與2010年道教南多書獎。Robson還是《力量的跡象：中國佛教中的符咒文字》、《博物館中的信仰：關於亞洲博物館與宗教場所交匯的思考》、以及《唐代禪宗木乃伊[肉身]與現代聖物盜竊案件？調查石頭希遷的爭議骨骸》的作者。他目前的研究項目包括關於日本佛教寺院與精神病院交匯歷史的長期研究計畫。
Jamie Hubbard
Professor of Religion and Yehan Numata Professor in Buddhist Studies at Smith College
美國史密斯學院宗教學教授、葉函沼田佛教研究教授
Jamie Hubbard graduated from the University of Wisconsin-Madison with a doctorate in Buddhist studies and has been teaching at Smith College since 1985. Hubbard is the author of books, articles and films on Buddhism in East Asia, including Pruning the Bodhi Tree (with Paul Swanson), Absolute Delusion, Perfect Buddhahood and the film The Yamaguchi Story: Buddhism and the Family in Japan. He also has extensive interests in the use of technology in Buddhist studies and has worked on numerous projects in the area of archiving Buddhist texts and digital publication, and more recently in the field of neuroscience and emerging technologies of awareness: Cyborg Buddha!
Jamie Hubbard於威斯康星大學麥迪遜分校獲得佛教研究博士學位，自1985年以來一直在史密斯學院任教。哈伯德是多本關於東亞佛教的書籍、文章及影片的作者，包括《修剪菩提樹》與Paul Swanson共同編著）、《絕對妄想、完美佛果》以及電影《山口故事：日本佛教與家庭》。他還對佛教研究中的科技應用有深入的興趣，並參與了多個有關佛教經典檔案管理與數字出版的項目，最近則關注於神經科學與新興的覺察技術領域，並進行相關的研究，項目名為《賽博格佛陀》。
美國史密斯學院宗教學教授、葉函沼田佛教研究教授
Jamie Hubbard graduated from the University of Wisconsin-Madison with a doctorate in Buddhist studies and has been teaching at Smith College since 1985. Hubbard is the author of books, articles and films on Buddhism in East Asia, including Pruning the Bodhi Tree (with Paul Swanson), Absolute Delusion, Perfect Buddhahood and the film The Yamaguchi Story: Buddhism and the Family in Japan. He also has extensive interests in the use of technology in Buddhist studies and has worked on numerous projects in the area of archiving Buddhist texts and digital publication, and more recently in the field of neuroscience and emerging technologies of awareness: Cyborg Buddha!
Jamie Hubbard於威斯康星大學麥迪遜分校獲得佛教研究博士學位，自1985年以來一直在史密斯學院任教。哈伯德是多本關於東亞佛教的書籍、文章及影片的作者，包括《修剪菩提樹》與Paul Swanson共同編著）、《絕對妄想、完美佛果》以及電影《山口故事：日本佛教與家庭》。他還對佛教研究中的科技應用有深入的興趣，並參與了多個有關佛教經典檔案管理與數字出版的項目，最近則關注於神經科學與新興的覺察技術領域，並進行相關的研究，項目名為《賽博格佛陀》。
Ching Keng 耿晴
Associate Professor in the Department of Philosophy, Director of the Center for Buddhist Studies at National Taiwan University
台灣大學佛學研究中心主任、哲學系副教授
Ching Keng (Ph.D., Harvard University, Committee on the Study of Religion, 2009) is currently an Associate Professor in the Department of Philosophy, Director of the Center for Buddhist Studies at National Taiwan University, and Editor-in-Chief of NTU Buddhist Studies. His research specialties include Yogācāra and Tathāgatagarbha thought. In recent years, she has also focused on Buddhist philosophy of consciousness, particularly discussions within the Abhidharma and Yogācāra traditions.
耿晴（2009年哈佛大學宗教委員會博士），現任哲學系副教授兼任台灣大學佛學研究中心主任暨《台大佛學研究》主編。研究專長為：唯識學、如來藏思想。近年來也關注佛教意識哲學、特別是在阿毘達磨和唯識學傳統中的討論。
台灣大學佛學研究中心主任、哲學系副教授
Ching Keng (Ph.D., Harvard University, Committee on the Study of Religion, 2009) is currently an Associate Professor in the Department of Philosophy, Director of the Center for Buddhist Studies at National Taiwan University, and Editor-in-Chief of NTU Buddhist Studies. His research specialties include Yogācāra and Tathāgatagarbha thought. In recent years, she has also focused on Buddhist philosophy of consciousness, particularly discussions within the Abhidharma and Yogācāra traditions.
耿晴（2009年哈佛大學宗教委員會博士），現任哲學系副教授兼任台灣大學佛學研究中心主任暨《台大佛學研究》主編。研究專長為：唯識學、如來藏思想。近年來也關注佛教意識哲學、特別是在阿毘達磨和唯識學傳統中的討論。
Robert Kritzer
Professor Emeritus at Kyoto Notre Dame University
京都聖母大學榮譽教授
Robert Kritzer is a professor emeritus at Kyoto Notre Dame University. He received his Ph.D. in Buddhist Studies from the University of California, Berkeley. His research interests, mainly in Indian Buddhism, include abhidharma, early Yogācāra, Buddhist embryology, and Buddhist theories of rebirth. He has published three books: Rebirth and Causation in the Yogācāra Abhidharma (Arbeitskreis für Tibetische und Buddhistische Studien, Universität Wien); Vasubandhu and the Yogācārabhūmi: Yogācāra Elements in the Abhidharmakośabhāṣya. (International Institute for Buddhist Studies); Garbhāvakrāntisūtra: The Sūtra on Entry into the Womb. Studia Philologica Buddhica, (International Institute for Buddhist Studies). Currently, he is translating Sangs rgyas kyi mdzod for the organization, 84,000.
Robert Kritzer是京都聖母大學的榮譽教授。他在加州大學柏克萊分校獲得佛教研究博士學位。他的研究興趣主要集中在印度佛教，包括阿毘達磨、早期瑜伽行派、佛教胎生學以及佛教的輪迴理論。他已出版三本專著：（《瑜伽行派阿毘達磨中的輪迴與因果》），由維也納大學西藏與佛教研究小組出版；（《世親與〈瑜伽師地論〉——〈阿毘達磨俱舍論〉中的瑜伽行派要素》），由國際佛學研究所出版;（《入胎經》）， 系列，由國際佛學研究所出版。目前，他正為「八萬四千」組織翻譯《佛藏論》.
京都聖母大學榮譽教授
Robert Kritzer is a professor emeritus at Kyoto Notre Dame University. He received his Ph.D. in Buddhist Studies from the University of California, Berkeley. His research interests, mainly in Indian Buddhism, include abhidharma, early Yogācāra, Buddhist embryology, and Buddhist theories of rebirth. He has published three books: Rebirth and Causation in the Yogācāra Abhidharma (Arbeitskreis für Tibetische und Buddhistische Studien, Universität Wien); Vasubandhu and the Yogācārabhūmi: Yogācāra Elements in the Abhidharmakośabhāṣya. (International Institute for Buddhist Studies); Garbhāvakrāntisūtra: The Sūtra on Entry into the Womb. Studia Philologica Buddhica, (International Institute for Buddhist Studies). Currently, he is translating Sangs rgyas kyi mdzod for the organization, 84,000.
Robert Kritzer是京都聖母大學的榮譽教授。他在加州大學柏克萊分校獲得佛教研究博士學位。他的研究興趣主要集中在印度佛教，包括阿毘達磨、早期瑜伽行派、佛教胎生學以及佛教的輪迴理論。他已出版三本專著：（《瑜伽行派阿毘達磨中的輪迴與因果》），由維也納大學西藏與佛教研究小組出版；（《世親與〈瑜伽師地論〉——〈阿毘達磨俱舍論〉中的瑜伽行派要素》），由國際佛學研究所出版;（《入胎經》）， 系列，由國際佛學研究所出版。目前，他正為「八萬四千」組織翻譯《佛藏論》.
Jacob H. Hanna
Principal Investigator at the Weizmann Institute of Science
以色列魏茲曼科學研究所首席研究員
Born in Rama, an Israeli Palestinian-Arab village in the Galilee region of Israel, Prof. Jacob (Yaqub) Hanna earned his BSc in medical science (2001), PhD in immunology (2007), and MD in clinical medicine summa cum laude (2007) from the Hebrew University of Jerusalem. He conducted postdoctoral research at the Whitehead Institute for Biomedical Research at MIT. He joined the department of Molecular Genetics at the Weizmann Institute in 2011.
Prof. Hanna is pioneering techniques in induced naïve pluripotency from adult cell and synthetic whole embryo models made solely from stem cells ex utero for regenerating new organs and tissues. Induced pluripotent stem (iPS) cells have regenerative properties almost identical to those of embryonic stem cells but can be created from adult cells without using an egg or fetal material. Prof. Hanna was the lead researcher in a study that showed how further-modified iPS cells could be used to treat sickle-cell anemia in mice, the first proof of concept of the therapeutic application of iPS cells. Prof. Hanna has uncovered novel pathways regulating the reprogramming process and was the first to derive pristine “naïve” human pluripotent cells equivalent to those derived from mice and (i) can generate “cross-species humanized chimeric” mouse models that have human derived tissues (ii) can give rise to human primordial germ cell (progenitors of egg or sperm) and restore fertility or (iii) to all extra-embryonic compartments (placenta and yolk-sac). He was the first to expand prolonged periods of advanced and normal mammalian embryo development from pre-gastrulation until late organogenesis in an “artificial uterus” environment outside the maternal womb. The latter platform enabled him to demonstrate the ability to be the first to generate advanced stage & whole synthetic embryos made entirely from naïve pluripotent stem cells in the petri dish, that can complete gastrulation and demonstrate organ formation within adequate extra-embryonic compartments. He adapted these approaches and was able to derive the first complete human embryo model equivalent to day 14 made from human naïve stem cells. In addition to demonstrating the power of cell reprogramming and ex utero advanced embryogenesis, his work offers the promise of new research models for restoring and rejuvenating organs, infertility, pregnancy failure and human tissue development.
Jacob (Yaqub) Hanna教授出生於以色列加利利地區的巴勒斯坦裔阿拉伯村莊拉瑪（Rama）。他於2001年獲得耶路撒冷希伯來大學醫學科學學士學位（BSc），2007年獲得免疫學博士學位（PhD），並以最高榮譽取得臨床醫學博士學位（MD）。隨後，他在**麻省理工學院（MIT）懷特黑德生物醫學研究所**進行博士後研究。2011年，他加入以色列魏茲曼科學研究所分子遺傳學系。Hanna教授在從體細胞誘導原始多能性以及利用幹細胞體外構建完整合成胚胎模型領域開創了先河，這些技術為器官與組織再生提供了新的可能性。**誘導多能幹細胞（iPS細胞）的再生特性幾乎與胚胎幹細胞相同，但可直接由成體細胞誘導產生，無需使用卵子或胎兒組織。Hanna教授領導的研究首次證明，經進一步改造的iPS細胞可用於治療鐮刀型貧血症**小鼠，這是iPS細胞臨床應用的首個概念驗證。此外，Hanna教授發現了調控重編程過程的新型通路，並率先成功誘導出與小鼠多能幹細胞相當的**「原始態」人類多能幹細胞**。這些細胞可用於：1. 生成「跨物種人源化嵌合體」小鼠模型，使其擁有由人類細胞衍生的組織；2. 分化為人類始基生殖細胞，即卵子或精子的前體細胞，並有潛力恢復生殖能力；分化為所有胚外組織，包括胎盤與卵黃3. 囊。Hanna教授還是首位在「人工子宮」環境中，成功將哺乳類胚胎的體外發育時間從原腸胚期延長至晚期器官生成期的科學家。這一平台使他能夠創造完全由原始態多能幹細胞（衍生的完整合成胚胎，該胚胎能夠順利完成原腸胚形成，並在適當的胚外組織環境內發育出器官。Hanna教授進一步應用這一技術，首次從人類原始態幹細胞構建出相當於14天發育階段的完整人類胚胎模型。除了展現細胞重編程與體外胚胎發育的潛力外，Hanna教授的研究為器官再生、恢復生育能力、治療妊娠失敗及促進人類組織發育開闢了新的研究方向。
以色列魏茲曼科學研究所首席研究員
Born in Rama, an Israeli Palestinian-Arab village in the Galilee region of Israel, Prof. Jacob (Yaqub) Hanna earned his BSc in medical science (2001), PhD in immunology (2007), and MD in clinical medicine summa cum laude (2007) from the Hebrew University of Jerusalem. He conducted postdoctoral research at the Whitehead Institute for Biomedical Research at MIT. He joined the department of Molecular Genetics at the Weizmann Institute in 2011.
Prof. Hanna is pioneering techniques in induced naïve pluripotency from adult cell and synthetic whole embryo models made solely from stem cells ex utero for regenerating new organs and tissues. Induced pluripotent stem (iPS) cells have regenerative properties almost identical to those of embryonic stem cells but can be created from adult cells without using an egg or fetal material. Prof. Hanna was the lead researcher in a study that showed how further-modified iPS cells could be used to treat sickle-cell anemia in mice, the first proof of concept of the therapeutic application of iPS cells. Prof. Hanna has uncovered novel pathways regulating the reprogramming process and was the first to derive pristine “naïve” human pluripotent cells equivalent to those derived from mice and (i) can generate “cross-species humanized chimeric” mouse models that have human derived tissues (ii) can give rise to human primordial germ cell (progenitors of egg or sperm) and restore fertility or (iii) to all extra-embryonic compartments (placenta and yolk-sac). He was the first to expand prolonged periods of advanced and normal mammalian embryo development from pre-gastrulation until late organogenesis in an “artificial uterus” environment outside the maternal womb. The latter platform enabled him to demonstrate the ability to be the first to generate advanced stage & whole synthetic embryos made entirely from naïve pluripotent stem cells in the petri dish, that can complete gastrulation and demonstrate organ formation within adequate extra-embryonic compartments. He adapted these approaches and was able to derive the first complete human embryo model equivalent to day 14 made from human naïve stem cells. In addition to demonstrating the power of cell reprogramming and ex utero advanced embryogenesis, his work offers the promise of new research models for restoring and rejuvenating organs, infertility, pregnancy failure and human tissue development.
Jacob (Yaqub) Hanna教授出生於以色列加利利地區的巴勒斯坦裔阿拉伯村莊拉瑪（Rama）。他於2001年獲得耶路撒冷希伯來大學醫學科學學士學位（BSc），2007年獲得免疫學博士學位（PhD），並以最高榮譽取得臨床醫學博士學位（MD）。隨後，他在**麻省理工學院（MIT）懷特黑德生物醫學研究所**進行博士後研究。2011年，他加入以色列魏茲曼科學研究所分子遺傳學系。Hanna教授在從體細胞誘導原始多能性以及利用幹細胞體外構建完整合成胚胎模型領域開創了先河，這些技術為器官與組織再生提供了新的可能性。**誘導多能幹細胞（iPS細胞）的再生特性幾乎與胚胎幹細胞相同，但可直接由成體細胞誘導產生，無需使用卵子或胎兒組織。Hanna教授領導的研究首次證明，經進一步改造的iPS細胞可用於治療鐮刀型貧血症**小鼠，這是iPS細胞臨床應用的首個概念驗證。此外，Hanna教授發現了調控重編程過程的新型通路，並率先成功誘導出與小鼠多能幹細胞相當的**「原始態」人類多能幹細胞**。這些細胞可用於：1. 生成「跨物種人源化嵌合體」小鼠模型，使其擁有由人類細胞衍生的組織；2. 分化為人類始基生殖細胞，即卵子或精子的前體細胞，並有潛力恢復生殖能力；分化為所有胚外組織，包括胎盤與卵黃3. 囊。Hanna教授還是首位在「人工子宮」環境中，成功將哺乳類胚胎的體外發育時間從原腸胚期延長至晚期器官生成期的科學家。這一平台使他能夠創造完全由原始態多能幹細胞（衍生的完整合成胚胎，該胚胎能夠順利完成原腸胚形成，並在適當的胚外組織環境內發育出器官。Hanna教授進一步應用這一技術，首次從人類原始態幹細胞構建出相當於14天發育階段的完整人類胚胎模型。除了展現細胞重編程與體外胚胎發育的潛力外，Hanna教授的研究為器官再生、恢復生育能力、治療妊娠失敗及促進人類組織發育開闢了新的研究方向。
Henry Austin
Fellow in Science, Technology and Society at Harvard University
哈佛大學科學、技術與社會研究員
Henry is a Research Associate with the Global Observatory for Genome Editing and a Fellow in the Harvard STS Program. Henry graduated from Harvard College in 2023, where he studied Social Studies, with a Secondary Field in Computer Science. Within the Global Observatory, Henry’s work has aimed to expand the range of questions asked about emergent technologies that are poised to reshape the meaning of human life.
Through the Harvard STS Program, his research has focused on the politics of datafication and memory, with a focus on the right to be forgotten and the remaking of state sovereignty in technological societies. His previous research projects have focused on the implications of decentralized biotechnology on knowledge production and public health, with attention to the bioconstitutional orders at stake in governing technological innovation and progress. Henry plans to attend law school this fall upon the conclusion of the Observatory project.
Henry 是全球基因編輯觀察站的研究助理，也是哈佛STS計劃的研究員。Henry 於2023年畢業於哈佛學院，主修社會研究，並輔修電腦科學。在全球觀察站中，Henry 的工作旨在拓展人們對於即將重塑人類生命意義的新興技術所提出的問題範疇。
透過哈佛STS計劃，他的研究聚焦於資料化與記憶的政治性，特別關注被遺忘的權利，以及在科技社會中國家主權的重塑。他先前的研究計劃聚焦於去中心化生物技術對知識生產與公共衛生的影響，並關注在治理科技創新與進步過程中所涉及的生物憲政秩序。Henry 計劃在觀察站項目結束後於今年秋季就讀法學院。
哈佛大學科學、技術與社會研究員
Henry is a Research Associate with the Global Observatory for Genome Editing and a Fellow in the Harvard STS Program. Henry graduated from Harvard College in 2023, where he studied Social Studies, with a Secondary Field in Computer Science. Within the Global Observatory, Henry’s work has aimed to expand the range of questions asked about emergent technologies that are poised to reshape the meaning of human life.
Through the Harvard STS Program, his research has focused on the politics of datafication and memory, with a focus on the right to be forgotten and the remaking of state sovereignty in technological societies. His previous research projects have focused on the implications of decentralized biotechnology on knowledge production and public health, with attention to the bioconstitutional orders at stake in governing technological innovation and progress. Henry plans to attend law school this fall upon the conclusion of the Observatory project.
Henry 是全球基因編輯觀察站的研究助理，也是哈佛STS計劃的研究員。Henry 於2023年畢業於哈佛學院，主修社會研究，並輔修電腦科學。在全球觀察站中，Henry 的工作旨在拓展人們對於即將重塑人類生命意義的新興技術所提出的問題範疇。
透過哈佛STS計劃，他的研究聚焦於資料化與記憶的政治性，特別關注被遺忘的權利，以及在科技社會中國家主權的重塑。他先前的研究計劃聚焦於去中心化生物技術對知識生產與公共衛生的影響，並關注在治理科技創新與進步過程中所涉及的生物憲政秩序。Henry 計劃在觀察站項目結束後於今年秋季就讀法學院。
Insoo Hyun
Director, Center for Life Sciences and Public Learning, Museum of Science, Boston
波士頓科學博物館生命科學與公共學習中心主任
Insoo Hyun is the inaugural director of the Center for Life Sciences and Public Learning at the Museum of Science in Boston and an Affiliate of the Center for Bioethics at Harvard Medical School (HMS). He is also HMS’ former Director of Research Ethics. Previous to his work at Harvard Medical School, he was professor of bioethics and philosophy at Case Western Reserve University School of Medicine for more than 18 years. Dr. Hyun’s research interests include stem cell ethics and policy, and emerging biotechnologies in the life sciences. Since 2005, Dr. Hyun has been heavily involved with the International Society for Stem Cell Research (ISSCR), helping draft its international research guidelines and serving twice as the chair of the ISSCR Ethics Committee. Dr. Hyun is also a member of NExTRAC, a federal advisory committee that provides recommendations to the NIH Director and a public forum for the discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies. He has served on national commissions for the Institute of Medicine and the National Academy of Sciences in Washington, DC. Dr. Hyun received his BA and MA in Philosophy with Honors in Ethics in Society from Stanford University and his PhD in Philosophy from Brown University.
玄仁秀是波士頓科學博物館生命科學與公共學習中心的首任主任，同時也是哈佛醫學院 (HMS）生物倫理中心的附屬學者，並曾擔任哈佛醫學院研究倫理主任。在加入哈佛醫學院之前，他在凱斯西儲大學醫學院擔任生物倫理與哲學教授長達18年以上。玄博士的研究興趣包括幹細胞倫理與政策，以及生命科學領域的新興生物技術。自2005年以來，他積極參與國際幹細胞研究學會(ISSCR），協助起草其國際研究指導方針，並兩度擔任ISSCR倫理委員會主席。此外，他也是NExTRAC（美國國立衛生研究院NIH的新興生物技術顧問委員會）的成員，該委員會向NIH主任提供建議，並為新興生物技術相關的科學、安全與倫理議題提供公共討論平台。他還曾在華盛頓特區為美國醫學研究所與美國國家科學院擔任全國性委員會的委員。玄博士於史丹佛大學獲得哲學學士與碩士學位，並榮獲「社會倫理學榮譽」，隨後在布朗大學獲得哲學博士學位。
波士頓科學博物館生命科學與公共學習中心主任
Insoo Hyun is the inaugural director of the Center for Life Sciences and Public Learning at the Museum of Science in Boston and an Affiliate of the Center for Bioethics at Harvard Medical School (HMS). He is also HMS’ former Director of Research Ethics. Previous to his work at Harvard Medical School, he was professor of bioethics and philosophy at Case Western Reserve University School of Medicine for more than 18 years. Dr. Hyun’s research interests include stem cell ethics and policy, and emerging biotechnologies in the life sciences. Since 2005, Dr. Hyun has been heavily involved with the International Society for Stem Cell Research (ISSCR), helping draft its international research guidelines and serving twice as the chair of the ISSCR Ethics Committee. Dr. Hyun is also a member of NExTRAC, a federal advisory committee that provides recommendations to the NIH Director and a public forum for the discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies. He has served on national commissions for the Institute of Medicine and the National Academy of Sciences in Washington, DC. Dr. Hyun received his BA and MA in Philosophy with Honors in Ethics in Society from Stanford University and his PhD in Philosophy from Brown University.
玄仁秀是波士頓科學博物館生命科學與公共學習中心的首任主任，同時也是哈佛醫學院 (HMS）生物倫理中心的附屬學者，並曾擔任哈佛醫學院研究倫理主任。在加入哈佛醫學院之前，他在凱斯西儲大學醫學院擔任生物倫理與哲學教授長達18年以上。玄博士的研究興趣包括幹細胞倫理與政策，以及生命科學領域的新興生物技術。自2005年以來，他積極參與國際幹細胞研究學會(ISSCR），協助起草其國際研究指導方針，並兩度擔任ISSCR倫理委員會主席。此外，他也是NExTRAC（美國國立衛生研究院NIH的新興生物技術顧問委員會）的成員，該委員會向NIH主任提供建議，並為新興生物技術相關的科學、安全與倫理議題提供公共討論平台。他還曾在華盛頓特區為美國醫學研究所與美國國家科學院擔任全國性委員會的委員。玄博士於史丹佛大學獲得哲學學士與碩士學位，並榮獲「社會倫理學榮譽」，隨後在布朗大學獲得哲學博士學位。
Somparn Promta
Director for the Center for the Study of Buddhist Philosophy at Mahachulalongkorn University
泰國瑪哈朱拉隆功大學佛教哲學研究中心主任
Somparn Promta is a professor of philosophy. He got his Ph.D. in philosophy from Chulalongkorn University. After completing his Ph.D. in 1991, he taught in the Philosophy Department at Chulalongkorn University from 1991-2016. After his retirement from Chulalongkorn in 2016, he joined Mahachulalongkorn University as the director of the Center for the Study of Buddhist Philosophy from 2016 until the present. Somparn has written several books that can be found on Amazon.com. His latest book is Buddhism and God: Does the Buddha Reject God (2023).
Somparn Promta 是一位哲學教授。他在朱拉隆功大學獲得哲學博士學位。1991年完成博士學位後，他於1991年至2016年間在朱拉隆功大學哲學系任教。2016年從朱拉隆功大學退休後，他加入瑪哈朱拉隆功大學，擔任佛教哲學研究中心主任，從2016年至今。Promta撰寫了多本書籍，可在 Amazon.com 上找到。他的最新著作是《佛教與上帝：佛陀否認上帝嗎？》（2023）。
泰國瑪哈朱拉隆功大學佛教哲學研究中心主任
Somparn Promta is a professor of philosophy. He got his Ph.D. in philosophy from Chulalongkorn University. After completing his Ph.D. in 1991, he taught in the Philosophy Department at Chulalongkorn University from 1991-2016. After his retirement from Chulalongkorn in 2016, he joined Mahachulalongkorn University as the director of the Center for the Study of Buddhist Philosophy from 2016 until the present. Somparn has written several books that can be found on Amazon.com. His latest book is Buddhism and God: Does the Buddha Reject God (2023).
Somparn Promta 是一位哲學教授。他在朱拉隆功大學獲得哲學博士學位。1991年完成博士學位後，他於1991年至2016年間在朱拉隆功大學哲學系任教。2016年從朱拉隆功大學退休後，他加入瑪哈朱拉隆功大學，擔任佛教哲學研究中心主任，從2016年至今。Promta撰寫了多本書籍，可在 Amazon.com 上找到。他的最新著作是《佛教與上帝：佛陀否認上帝嗎？》（2023）。
Amy Langenberg
Professor of Religious Studies at Eckerd College, USA
美國埃克德學院宗教學系教授
Amy Paris Langenberg is Professor of Religious Studies at Eckerd College in Florida, USA. She specializes in South Asian Buddhism, with a focus on gender, sexuality, and female monasticisms. She is author of Birth in Buddhism: The Suffering Fetus and Female Freedom (Routledge, 2017) and has published articles in History of Religions, the Journal of the American Academy of Religion, Religion Compass, Religious Studies Review, and the Journal of Global Buddhism. Her most recent project is a study of sexual abuse in North American and transnational Buddhism, co-written with Ann Gleig, to be published in 2026 by Yale University Press.
Amy Paris Langenberg 是美國佛羅里達州艾克德學院宗教研究系的教授。她專門研究南亞佛教，關注性別、性以及女性僧團。她是《佛教中的誕生：受苦的胎兒與女性自由》，(2017年）的作者，並在《宗教史》、《美國宗教學院期刊》、《宗教指南》、《宗教研究評論》及《全球佛教期刊》等學術期刊上發表過論文。她最新的研究項目是一項關於北美及跨國佛教界性侵害問題的研究，Ann Gleig合著，該書將於2026年由耶魯大學出版社出版。
美國埃克德學院宗教學系教授
Amy Paris Langenberg is Professor of Religious Studies at Eckerd College in Florida, USA. She specializes in South Asian Buddhism, with a focus on gender, sexuality, and female monasticisms. She is author of Birth in Buddhism: The Suffering Fetus and Female Freedom (Routledge, 2017) and has published articles in History of Religions, the Journal of the American Academy of Religion, Religion Compass, Religious Studies Review, and the Journal of Global Buddhism. Her most recent project is a study of sexual abuse in North American and transnational Buddhism, co-written with Ann Gleig, to be published in 2026 by Yale University Press.
Amy Paris Langenberg 是美國佛羅里達州艾克德學院宗教研究系的教授。她專門研究南亞佛教，關注性別、性以及女性僧團。她是《佛教中的誕生：受苦的胎兒與女性自由》，(2017年）的作者，並在《宗教史》、《美國宗教學院期刊》、《宗教指南》、《宗教研究評論》及《全球佛教期刊》等學術期刊上發表過論文。她最新的研究項目是一項關於北美及跨國佛教界性侵害問題的研究，Ann Gleig合著，該書將於2026年由耶魯大學出版社出版。
James Hughes
Executive Director and Associate Provost at the Institute for Ethics and Emerging Technologies at the University of Massachusetts Boston
麻薩諸塞大學波士頓分校倫理與新興技術研究所執行主任兼副教務長
James “J.” Hughes is a former Theravadan monk and aspiring Buddhist scholar. He serves as Associate Provost for the University of Massachusetts Boston (UMB) and as a senior research fellow at UMB’s Applied Ethics Center. He is a bioethicist and sociologist, and has taught health policy, bioethics, Buddhism, medical sociology, and research methods at Northwestern University, the University of Connecticut, and Trinity College. He is the author of Citizen Cyborg: Why Democratic Societies Must Respond to the Redesigned Human of the Future (2004) and co-editor of Surviving the Machine Age: Intelligent Technology and the Transformation of Human Work (2017) and The Biopolitics of Human Enhancement (2025). In 2005 he co-founded the Institute for Ethics and Emerging Technologies (IEET) with Oxford philosopher Nick Bostrom, and since then has served as its executive director, and as associate editor of the IEET’s Journal of Evolution and Technology.
James "J." Hughes曾是一名上座部佛教僧侶，並立志成為佛學研究者。他現任麻薩諸塞大學波士頓分校（ UMB）副教務長兼應用倫理中心的高級研究員。Hughes 是一位生物倫理學家與社會學家，曾在西北大學、康乃狄克大學及三一學院教授健康政策、生物倫理學、佛學、醫療社會學及研究方法論。他著有《公民賽博格：為何民主社會必須回應未來經過設計的人類》（2004），並擔任《機械時代的生存：智能技術與人類工作的轉型》（2017）及《人類增強的生物政治學》(2025）的共同編輯。2005年，他與牛津哲學家Nick Bostrom共同創立倫理與新興技術研究所 (IEET），自創立以來一直擔任該機構的執行董事，並兼任其《進化與技術期刊》的副主編。
麻薩諸塞大學波士頓分校倫理與新興技術研究所執行主任兼副教務長
James “J.” Hughes is a former Theravadan monk and aspiring Buddhist scholar. He serves as Associate Provost for the University of Massachusetts Boston (UMB) and as a senior research fellow at UMB’s Applied Ethics Center. He is a bioethicist and sociologist, and has taught health policy, bioethics, Buddhism, medical sociology, and research methods at Northwestern University, the University of Connecticut, and Trinity College. He is the author of Citizen Cyborg: Why Democratic Societies Must Respond to the Redesigned Human of the Future (2004) and co-editor of Surviving the Machine Age: Intelligent Technology and the Transformation of Human Work (2017) and The Biopolitics of Human Enhancement (2025). In 2005 he co-founded the Institute for Ethics and Emerging Technologies (IEET) with Oxford philosopher Nick Bostrom, and since then has served as its executive director, and as associate editor of the IEET’s Journal of Evolution and Technology.
James "J." Hughes曾是一名上座部佛教僧侶，並立志成為佛學研究者。他現任麻薩諸塞大學波士頓分校（ UMB）副教務長兼應用倫理中心的高級研究員。Hughes 是一位生物倫理學家與社會學家，曾在西北大學、康乃狄克大學及三一學院教授健康政策、生物倫理學、佛學、醫療社會學及研究方法論。他著有《公民賽博格：為何民主社會必須回應未來經過設計的人類》（2004），並擔任《機械時代的生存：智能技術與人類工作的轉型》（2017）及《人類增強的生物政治學》(2025）的共同編輯。2005年，他與牛津哲學家Nick Bostrom共同創立倫理與新興技術研究所 (IEET），自創立以來一直擔任該機構的執行董事，並兼任其《進化與技術期刊》的副主編。
Shizuko Takahashi
Research Fellow at the Center for Biomedical Ethics at National University of Singapore
新加坡國立大學生物醫學倫理中心研究員
Shizuko is currently a Research Fellow at the Center for Biomedical Ethics (CbmE), National University of Singapore. She is trained in reproductive medicine and has worked as a certified Obstetrician, Gynecologist, and Clinical Geneticist at multiple hospitals in Tokyo. In 2011, she became the first physician to earn a PhD from the University of Tokyo’s Department of Biomedical Ethics and later became faculty (part-time).
Her research is deeply interdisciplinary, encompassing domestic and international ethical regulations, government policies, public attitudes, and practices, with a strong focus on reproductive technologies. She has been an educator at the University of Tokyo and Yale University, teaching bioethics and medical ethics to students worldwide.
In addition to her academic work, Shizuko is also a children’s book writer and illustrator. She was awarded the Women’s Challenge Award at the G7 ministerial meeting in Japan in 2023 for her book, “The World Caught a Cold”, which addresses the COVID-19 pandemic. She has also written books on sex-education with Sanrio. Currently, another children’s book on genetics starting from the embryo is underway.
Her recent projects continue to reflect her ongoing interest in genetics, reproductive medicine, and pediatrics.
Shizuko
目前是新加坡國立大學生醫倫理中心的研究員。她受過生殖醫學專業訓練，並曾在東京多家醫院擔任合格的產科醫師、婦科醫師與臨床遺傳醫師。2011年，她成為東京大學生物醫學倫理學系首位獲得博士學位的醫師，之後也以兼任身份擔任該系教職。
她的研究領域高度跨學科，涵蓋國內外倫理規範、政府政策、大眾態度與實務操作，並特別關注於生殖科技。Shizuko曾在東京大學與耶魯大學教授生命倫理與醫學倫理，對象為來自世界各地的學生。
除了學術工作之外，Shizuko也是一位兒童繪本作家與插畫家。她的繪本《世界感冒了》，以COVID-19疫情為主題，在2023年榮獲G7日本部長級會議頒發的女性挑戰獎。她也與三麗鷗合作出版性教育相關的書籍。目前，她正在創作另一本以胚胎為起點、講述遺傳學的兒童繪本。
她近期的研究計畫，仍持續圍繞遺傳學、生殖醫學與小兒醫學等領域，展現她在這些主題上的長期關注與投入。
新加坡國立大學生物醫學倫理中心研究員
Shizuko is currently a Research Fellow at the Center for Biomedical Ethics (CbmE), National University of Singapore. She is trained in reproductive medicine and has worked as a certified Obstetrician, Gynecologist, and Clinical Geneticist at multiple hospitals in Tokyo. In 2011, she became the first physician to earn a PhD from the University of Tokyo’s Department of Biomedical Ethics and later became faculty (part-time).
Her research is deeply interdisciplinary, encompassing domestic and international ethical regulations, government policies, public attitudes, and practices, with a strong focus on reproductive technologies. She has been an educator at the University of Tokyo and Yale University, teaching bioethics and medical ethics to students worldwide.
In addition to her academic work, Shizuko is also a children’s book writer and illustrator. She was awarded the Women’s Challenge Award at the G7 ministerial meeting in Japan in 2023 for her book, “The World Caught a Cold”, which addresses the COVID-19 pandemic. She has also written books on sex-education with Sanrio. Currently, another children’s book on genetics starting from the embryo is underway.
Her recent projects continue to reflect her ongoing interest in genetics, reproductive medicine, and pediatrics.
Shizuko
目前是新加坡國立大學生醫倫理中心的研究員。她受過生殖醫學專業訓練，並曾在東京多家醫院擔任合格的產科醫師、婦科醫師與臨床遺傳醫師。2011年，她成為東京大學生物醫學倫理學系首位獲得博士學位的醫師，之後也以兼任身份擔任該系教職。
她的研究領域高度跨學科，涵蓋國內外倫理規範、政府政策、大眾態度與實務操作，並特別關注於生殖科技。Shizuko曾在東京大學與耶魯大學教授生命倫理與醫學倫理，對象為來自世界各地的學生。
除了學術工作之外，Shizuko也是一位兒童繪本作家與插畫家。她的繪本《世界感冒了》，以COVID-19疫情為主題，在2023年榮獲G7日本部長級會議頒發的女性挑戰獎。她也與三麗鷗合作出版性教育相關的書籍。目前，她正在創作另一本以胚胎為起點、講述遺傳學的兒童繪本。
她近期的研究計畫，仍持續圍繞遺傳學、生殖醫學與小兒醫學等領域，展現她在這些主題上的長期關注與投入。
Siddharth Jhunjhunwala
Associate Professor in the Department of Bioengineering at the Indian Institute of Science
印度科學研究院生物工程系副教授
Siddharth Jhunjhunwala is an Associate Professor at the Department of Bioengineering, Indian Institute of Science, Bengaluru, India. He is currently a DBT-Wellcome India Alliance Intermediate Fellow, and in the past has been awarded the Ramanujan Fellowship and the R.I. Mazumdar young investigator position at IISc. Siddharth’s research interests are in the field of immunoengineering. His laboratory’s goal is to develop techniques to modulate neutrophil and macrophage functions in diseases such as type-2 diabetes and its complications.
Siddharth Jhunjhunwala
是印度班加羅爾印度科學研究院生物工程系的副教授。他目前是DBT-Wellcome印度聯盟的中階研究員，過去曾獲得拉馬努金獎學金以及印度科學研究院的R.I. Mazumdar青年研究員職位。Jhunjhunwala的研究興趣主要集中在免疫工程領域。他的實驗室致力於開發技術，以調控嗜中性白血球與巨噬細胞在第二型糖尿病及其併發症等疾病中的功能。
印度科學研究院生物工程系副教授
Siddharth Jhunjhunwala is an Associate Professor at the Department of Bioengineering, Indian Institute of Science, Bengaluru, India. He is currently a DBT-Wellcome India Alliance Intermediate Fellow, and in the past has been awarded the Ramanujan Fellowship and the R.I. Mazumdar young investigator position at IISc. Siddharth’s research interests are in the field of immunoengineering. His laboratory’s goal is to develop techniques to modulate neutrophil and macrophage functions in diseases such as type-2 diabetes and its complications.
Siddharth Jhunjhunwala
是印度班加羅爾印度科學研究院生物工程系的副教授。他目前是DBT-Wellcome印度聯盟的中階研究員，過去曾獲得拉馬努金獎學金以及印度科學研究院的R.I. Mazumdar青年研究員職位。Jhunjhunwala的研究興趣主要集中在免疫工程領域。他的實驗室致力於開發技術，以調控嗜中性白血球與巨噬細胞在第二型糖尿病及其併發症等疾病中的功能。
Michael Levin
Professor of Biology and Biomedical Engineering at Tufts University
塔夫茨大學生物學與生物醫學工程教授
Michael Levin is currently Distinguished Vannever Bush Professor in the biology department at Tufts University and associate faculty at Harvard's Wyss Institute. He serves as founding director of the Allen Discovery Center at Tufts, and co-director of the Institute for Computer Designed Organisms. He received dual bachelors' degrees in Computer Science and Biology, and a Ph.D. in genetics from Harvard University. His laboratory integrates biology, computer science, and cognitive science toward an understanding of intelligence in a wide range of evolved, engineered, and hybrid systems. Applications of the work range across regenerative medicine, bioengineering, AI, and philosophy of mind.
Michael Levin 目前擔任塔夫茨大學生物系的 Vannevar Bush 傑出教授，並兼任哈佛大學 Wyss 研究所的協同教職。他是塔夫茨大學 Allen 探索中心（Allen Discovery Center）的創始主任，並共同擔任「電腦設計有機體研究所」（Institute for Computer Designed Organisms）的聯合主任。他於哈佛大學獲得電腦科學與生物學雙學士學位，以及遺傳學博士學位。他的實驗室結合生物學、電腦科學與認知科學，致力於理解各種自然演化、人工設計與混合系統中的智慧現象。其研究應用涵蓋再生醫學、生物工程、人工智慧以及心靈哲學等領域。
塔夫茨大學生物學與生物醫學工程教授
Michael Levin is currently Distinguished Vannever Bush Professor in the biology department at Tufts University and associate faculty at Harvard's Wyss Institute. He serves as founding director of the Allen Discovery Center at Tufts, and co-director of the Institute for Computer Designed Organisms. He received dual bachelors' degrees in Computer Science and Biology, and a Ph.D. in genetics from Harvard University. His laboratory integrates biology, computer science, and cognitive science toward an understanding of intelligence in a wide range of evolved, engineered, and hybrid systems. Applications of the work range across regenerative medicine, bioengineering, AI, and philosophy of mind.
Michael Levin 目前擔任塔夫茨大學生物系的 Vannevar Bush 傑出教授，並兼任哈佛大學 Wyss 研究所的協同教職。他是塔夫茨大學 Allen 探索中心（Allen Discovery Center）的創始主任，並共同擔任「電腦設計有機體研究所」（Institute for Computer Designed Organisms）的聯合主任。他於哈佛大學獲得電腦科學與生物學雙學士學位，以及遺傳學博士學位。他的實驗室結合生物學、電腦科學與認知科學，致力於理解各種自然演化、人工設計與混合系統中的智慧現象。其研究應用涵蓋再生醫學、生物工程、人工智慧以及心靈哲學等領域。
Josie Zayner
Founder and CEO of The ODIN
The ODIN 創辦人兼執行長
Dr. Josie Zayner is a visionary biochemist and genetic designer. For over 15 years, she has pioneered work in the field of bioengineering, publishing a number of scientific papers on the topic. Josie received her PhD in Biophysics from the University of Chicago, winning several awards for their work on engineering proteins. She then spearheaded work on developing engineered microbes for Mars terraforming at NASA, eventually leaving to start a genetic engineering company The Los Angeles Project based in Austin, Texas. Zayner’s groundbreaking work in genetic engineering and medicine has been the focus of many documentaries, including the Netflix documentary Unnatural Selection and the NYT documentary Gut Hack. She has been made fun of on Last Week Tonight with John Oliver and written about in media all over the world including The New York Times, The New Yorker, El País, Le Monde, Time, Scientific American and NPR, among others. Somehow Josie still finds time to be an accomplished artist whose work has been featured in exhibits at San Francisco MoMA, Philadelphia Museum of Art, NY MoMA, ZKM and the Smithsonian.
Josie Zayner 博士是一位具有遠見的生物化學家與基因設計師。十五年來，她在生物工程領域中走在前沿，發表了多篇相關的科學論文。Josie 於芝加哥大學獲得生物物理學博士學位，並因其在蛋白質工程方面的研究而多次獲獎。隨後，她在美國太空總署（NASA）領導了開發可用於火星地貌改造的工程微生物計劃，之後離開 NASA，創辦了位於德州奧斯汀的基因工程公司 The Los Angeles Project。
Zayner 在基因工程與醫學領域的開創性工作曾被多部紀錄片聚焦，包括 Netflix 的《Unnatural Selection》與《紐約時報》製作的紀錄片《Gut Hack》。她也曾在節目《Last Week Tonight with John Oliver》中被調侃，並被世界各地的媒體報導，包括《紐約時報》、《紐約客》、《國家報》（El País）、《世界報》（Le Monde）、《時代雜誌》、《科學人》與 NPR 等。
儘管如此，Josie 仍然是一位成就斐然的藝術家，其作品曾在舊金山現代藝術博物館（San Francisco MoMA）、費城藝術博物館、紐約現代藝術博物館（NY MoMA）、德國 ZKM 藝術與媒體中心，以及史密森尼博物館展出。
The ODIN 創辦人兼執行長
Dr. Josie Zayner is a visionary biochemist and genetic designer. For over 15 years, she has pioneered work in the field of bioengineering, publishing a number of scientific papers on the topic. Josie received her PhD in Biophysics from the University of Chicago, winning several awards for their work on engineering proteins. She then spearheaded work on developing engineered microbes for Mars terraforming at NASA, eventually leaving to start a genetic engineering company The Los Angeles Project based in Austin, Texas. Zayner’s groundbreaking work in genetic engineering and medicine has been the focus of many documentaries, including the Netflix documentary Unnatural Selection and the NYT documentary Gut Hack. She has been made fun of on Last Week Tonight with John Oliver and written about in media all over the world including The New York Times, The New Yorker, El País, Le Monde, Time, Scientific American and NPR, among others. Somehow Josie still finds time to be an accomplished artist whose work has been featured in exhibits at San Francisco MoMA, Philadelphia Museum of Art, NY MoMA, ZKM and the Smithsonian.
Josie Zayner 博士是一位具有遠見的生物化學家與基因設計師。十五年來，她在生物工程領域中走在前沿，發表了多篇相關的科學論文。Josie 於芝加哥大學獲得生物物理學博士學位，並因其在蛋白質工程方面的研究而多次獲獎。隨後，她在美國太空總署（NASA）領導了開發可用於火星地貌改造的工程微生物計劃，之後離開 NASA，創辦了位於德州奧斯汀的基因工程公司 The Los Angeles Project。
Zayner 在基因工程與醫學領域的開創性工作曾被多部紀錄片聚焦，包括 Netflix 的《Unnatural Selection》與《紐約時報》製作的紀錄片《Gut Hack》。她也曾在節目《Last Week Tonight with John Oliver》中被調侃，並被世界各地的媒體報導，包括《紐約時報》、《紐約客》、《國家報》（El País）、《世界報》（Le Monde）、《時代雜誌》、《科學人》與 NPR 等。
儘管如此，Josie 仍然是一位成就斐然的藝術家，其作品曾在舊金山現代藝術博物館（San Francisco MoMA）、費城藝術博物館、紐約現代藝術博物館（NY MoMA）、德國 ZKM 藝術與媒體中心，以及史密森尼博物館展出。
Sheila Jasanoff
Pforzheimer Professor of Science and Technology Studies at the Harvard Kennedy School
哈佛甘迺迪政府學院 Pforzheimer 科學與科技研究講座教授
Sheila Jasanoff is Pforzheimer Professor of Science and Technology Studies at the Harvard Kennedy School. A pioneer in her field, she has authored more than 130 articles and chapters and is author or editor of more than 15 books, including The Fifth Branch, Science at the Bar, Designs on Nature, The Ethics of Invention, and Can Science Make Sense of Life? Her work explores the role of science and technology in the law, politics, and policy of modern democracies. She founded and directs the STS Program at Harvard; previously, she was founding chair of the STS Department at Cornell.
Sheila Jasanoff 是哈佛甘迺迪政府學院的 Pforzheimer 科學與科技研究講座教授。作為該領域的先驅，她撰寫了超過130篇文章與章節，並著有或主編超過15本書籍，包括《第五權力》、《法庭上的科學》、《自然的設計》、《發明的倫理》，以及《科學能理解生命嗎？》。她的研究探討科學與科技在現代民主國家的法律、政治與政策中的角色。她創立並主持哈佛大學的科學與科技研究計劃（STS Program），此前亦曾擔任康乃爾大學科學與科技研究系的創系主任。
哈佛甘迺迪政府學院 Pforzheimer 科學與科技研究講座教授
Sheila Jasanoff is Pforzheimer Professor of Science and Technology Studies at the Harvard Kennedy School. A pioneer in her field, she has authored more than 130 articles and chapters and is author or editor of more than 15 books, including The Fifth Branch, Science at the Bar, Designs on Nature, The Ethics of Invention, and Can Science Make Sense of Life? Her work explores the role of science and technology in the law, politics, and policy of modern democracies. She founded and directs the STS Program at Harvard; previously, she was founding chair of the STS Department at Cornell.
Sheila Jasanoff 是哈佛甘迺迪政府學院的 Pforzheimer 科學與科技研究講座教授。作為該領域的先驅，她撰寫了超過130篇文章與章節，並著有或主編超過15本書籍，包括《第五權力》、《法庭上的科學》、《自然的設計》、《發明的倫理》，以及《科學能理解生命嗎？》。她的研究探討科學與科技在現代民主國家的法律、政治與政策中的角色。她創立並主持哈佛大學的科學與科技研究計劃（STS Program），此前亦曾擔任康乃爾大學科學與科技研究系的創系主任。
Ben Hurlbut
Professor in Department of Life Sciences at the University of Arizona
亞利桑那大學生命科學系教授
J. Benjamin Hurlbut, PhD is Associate Professor in the School of Life Sciences at Arizona State University. He is trained in science and technology studies (STS) with a focus on the history of the modern biomedical and life sciences, and his research lies at the intersection of intersection of STS, bioethics and political theory. He studies the changing relationships between science, politics and law in the governance of biomedical research and innovation, examining the interplay of science and technology with democracy, religious and moral pluralism, and public reason. He is the author of Experiments in Democracy: Human Embryo Research and the Politics of Bioethics (Columbia University Press, 2017) and co-editor of Perfecting Human Futures: Transhuman Visions and Technological Imaginations, (Dordrecht: Springer, 2016), as well as numerous articles and book chapters. He holds an A.B. from Stanford University and a Ph.D. in the History of Science from Harvard University. He was a postdoctoral fellow in the program on Science, Technology and Society at the Harvard Kennedy School.
J. Benjamin Hurlbut, PhD，是亞利桑那州立大學生命科學學院的副教授，專門研究科學與技術研究（STS），關注現代生物醫學與生命科學的歷史。他的研究位於STS、生物倫理學和政治理論的交叉點，探討科學、政治與法律在生物醫學研究與創新治理中的變化，並研究科學技術如何與民主、宗教與道德多元性及公共理性相互作用。他著有《民主中的實驗：人類胚胎研究與生物倫理政治》（哥倫比亞大學出版社，2017），並合編《完美人類未來：超人類主義視野與技術想像》（Springer，2016），另發表多篇學術論文與書籍章節。他在史丹佛大學獲得學士學位，並在哈佛大學獲得科學史博士學位，曾在哈佛甘迺迪學院的科學、技術與社會計劃擔任博士後研究員。
亞利桑那大學生命科學系教授
J. Benjamin Hurlbut, PhD is Associate Professor in the School of Life Sciences at Arizona State University. He is trained in science and technology studies (STS) with a focus on the history of the modern biomedical and life sciences, and his research lies at the intersection of intersection of STS, bioethics and political theory. He studies the changing relationships between science, politics and law in the governance of biomedical research and innovation, examining the interplay of science and technology with democracy, religious and moral pluralism, and public reason. He is the author of Experiments in Democracy: Human Embryo Research and the Politics of Bioethics (Columbia University Press, 2017) and co-editor of Perfecting Human Futures: Transhuman Visions and Technological Imaginations, (Dordrecht: Springer, 2016), as well as numerous articles and book chapters. He holds an A.B. from Stanford University and a Ph.D. in the History of Science from Harvard University. He was a postdoctoral fellow in the program on Science, Technology and Society at the Harvard Kennedy School.
J. Benjamin Hurlbut, PhD，是亞利桑那州立大學生命科學學院的副教授，專門研究科學與技術研究（STS），關注現代生物醫學與生命科學的歷史。他的研究位於STS、生物倫理學和政治理論的交叉點，探討科學、政治與法律在生物醫學研究與創新治理中的變化，並研究科學技術如何與民主、宗教與道德多元性及公共理性相互作用。他著有《民主中的實驗：人類胚胎研究與生物倫理政治》（哥倫比亞大學出版社，2017），並合編《完美人類未來：超人類主義視野與技術想像》（Springer，2016），另發表多篇學術論文與書籍章節。他在史丹佛大學獲得學士學位，並在哈佛大學獲得科學史博士學位，曾在哈佛甘迺迪學院的科學、技術與社會計劃擔任博士後研究員。
Jeff Hardin
Professor in Department of Integrated Biology at University of Wisconsin- Madison
威斯康辛大學麥迪遜分校綜合生物學系教授
Dr. Jeff Hardin is a Professor of Zoology at the University of Wisconsin–Madison and Chair of the Department of Integrative Biology. He earned his Ph.D. in Biophysics from the University of California, Berkeley, where he studied morphogenetic movements during embryonic development. A leading developmental biologist, Dr. Hardin uses the C. elegans embryo to explore the mechanisms of cell movement and cell adhesion, processes essential for proper tissue formation. His work has significant implications for understanding birth defects and cancer progression. Dr. Hardin has published extensively on morphogenesis and cell junction dynamics, and has also contributed to science education as Faculty Director of UW's Biology Core Curriculum. He is a recipient of numerous teaching and research awards, including the NSF Young Investigator Award and the Chancellor’s Distinguished Teaching Award.
Jeff Hardin 博士是威斯康辛大學麥迪遜分校動物學系教授，並擔任綜合生物學系主任。他於加州大學柏克萊分校取得生物物理學博士學位，研究胚胎發育過程中的形態發生運動。作為發育生物學的領軍人物，Hardin 博士使用秀麗隱桿線蟲 (C. elegans) 胚胎作為模型，探討細胞移動與細胞黏附的機制，這些過程對於正常組織形成至關重要。他的研究對理解人類發育過程中的先天缺陷與癌症進程具有重要意義。Hardin 博士在形態發生與細胞接合動態方面發表了大量論文，並身兼威斯康辛大學生物核心課程（Biocore）教學主任，致力於科學教育。他曾獲得多項教學與研究獎項，包括美國國家科學基金會青年研究員獎與校長卓越教學獎。
威斯康辛大學麥迪遜分校綜合生物學系教授
Dr. Jeff Hardin is a Professor of Zoology at the University of Wisconsin–Madison and Chair of the Department of Integrative Biology. He earned his Ph.D. in Biophysics from the University of California, Berkeley, where he studied morphogenetic movements during embryonic development. A leading developmental biologist, Dr. Hardin uses the C. elegans embryo to explore the mechanisms of cell movement and cell adhesion, processes essential for proper tissue formation. His work has significant implications for understanding birth defects and cancer progression. Dr. Hardin has published extensively on morphogenesis and cell junction dynamics, and has also contributed to science education as Faculty Director of UW's Biology Core Curriculum. He is a recipient of numerous teaching and research awards, including the NSF Young Investigator Award and the Chancellor’s Distinguished Teaching Award.
Jeff Hardin 博士是威斯康辛大學麥迪遜分校動物學系教授，並擔任綜合生物學系主任。他於加州大學柏克萊分校取得生物物理學博士學位，研究胚胎發育過程中的形態發生運動。作為發育生物學的領軍人物，Hardin 博士使用秀麗隱桿線蟲 (C. elegans) 胚胎作為模型，探討細胞移動與細胞黏附的機制，這些過程對於正常組織形成至關重要。他的研究對理解人類發育過程中的先天缺陷與癌症進程具有重要意義。Hardin 博士在形態發生與細胞接合動態方面發表了大量論文，並身兼威斯康辛大學生物核心課程（Biocore）教學主任，致力於科學教育。他曾獲得多項教學與研究獎項，包括美國國家科學基金會青年研究員獎與校長卓越教學獎。
David Kong
Director, Community Biotechnology Initiative; Research Scientist at MIT
麻省理工學院社區生物技術計劃主任／研究科學家
Dr. David Sun Kong is a synthetic biologist, bio-designer, community organizer, musician, and photographer based in Lexington, Massachusetts. He serves as the Director of the Community Biotechnology Initiative at the MIT Media Lab, where his research spans synthetic biology, biological design, collective intelligence, and STEAM education. Dr. Kong pioneered innovations such as “lab-on-a-chip” technologies and founded Metafluidics, an open-source repository for fluidic systems. He is also the founder of the Global Community Bio Summit and co-founder of the international course “How to Grow (Almost) Anything.” Beyond his scientific endeavors, Dr. Kong is an accomplished musician and artist, with performances at venues like South by Southwest and exhibitions at institutions including the Smithsonian and the Japanese American National Museum.
孔大衛博士是一位合成生物學家、生物設計師、社區組織者、音樂家與攝影師，現居美國麻薩諸塞州列克星敦。 他擔任麻省理工學院媒體實驗室社區生物技術計劃的主任，研究領域涵蓋合成生物學、生物設計、集體智慧與STEAM教育。 孔博士開創了「實驗室晶片」（lab-on-a-chip）等創新技術，並創立了開源流體系統資料庫Metafluidics。 他亦是全球社區生物高峰會（Global Community Bio Summit）的創辦人，以及國際課程「如何培養（幾乎）任何事物」（How to Grow (Almost) Anything）的共同創辦人。 除了科學研究外，孔博士也是一位成就斐然的音樂家與藝術家，曾在South by Southwest等地演出，作品亦於史密森尼博物館與美國日裔國家博物館等機構展出。
麻省理工學院社區生物技術計劃主任／研究科學家
Dr. David Sun Kong is a synthetic biologist, bio-designer, community organizer, musician, and photographer based in Lexington, Massachusetts. He serves as the Director of the Community Biotechnology Initiative at the MIT Media Lab, where his research spans synthetic biology, biological design, collective intelligence, and STEAM education. Dr. Kong pioneered innovations such as “lab-on-a-chip” technologies and founded Metafluidics, an open-source repository for fluidic systems. He is also the founder of the Global Community Bio Summit and co-founder of the international course “How to Grow (Almost) Anything.” Beyond his scientific endeavors, Dr. Kong is an accomplished musician and artist, with performances at venues like South by Southwest and exhibitions at institutions including the Smithsonian and the Japanese American National Museum.
孔大衛博士是一位合成生物學家、生物設計師、社區組織者、音樂家與攝影師，現居美國麻薩諸塞州列克星敦。 他擔任麻省理工學院媒體實驗室社區生物技術計劃的主任，研究領域涵蓋合成生物學、生物設計、集體智慧與STEAM教育。 孔博士開創了「實驗室晶片」（lab-on-a-chip）等創新技術，並創立了開源流體系統資料庫Metafluidics。 他亦是全球社區生物高峰會（Global Community Bio Summit）的創辦人，以及國際課程「如何培養（幾乎）任何事物」（How to Grow (Almost) Anything）的共同創辦人。 除了科學研究外，孔博士也是一位成就斐然的音樂家與藝術家，曾在South by Southwest等地演出，作品亦於史密森尼博物館與美國日裔國家博物館等機構展出。
Tsai-Ju Chien 簡采汝
Attending Physician in the Division of Hematology/Oncology Department of Medicine at Taipei City Hospital
台北市立聯合醫院內科部血液腫瘤科主治醫師
Dr. Tsai-Ju, Chien, grew up and received education in Taiwan, is a Buddhism Nun as well as a Hema-Oncologist. She has devoted to be a nun after complete chief resident training and then still keep her career in cancer care. She is an idealism in connecting the Buddhism and clinical medicine, and also experienced in cancer patient’s care from a holistic perspective, take care of their physical disease as well as spiritual care. The unique character of her is that she also possesses Traditional Chinese Medicine and has applied TCM in cancer patients for years. Dr. Chien is now as an assistant professor in Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, devoting her-self in integrating TCM in cancer care. Though she works in a western- medicine based City public hospital, she spends a lot time in TCM research and clinical practice. The reason is that she has observed so many cancer patients, who suffered from cancer- related symptom seeking for TCM help but hesitate to discuss with their clinical physicians, she wants to do something to coordinate these two branches of medicine (cultures) and meaningful to patients. Based on her clinical experience and research, some TCM indeed has the potential in improving symptoms related to cancer or enhancing efficiency of chemotherapy with confirmed safety. The mechanism is intriguing; some are compatible with immune stimulation theory yet need further study. Dr. Chien is pre-eminent in the field of Integrative Medicine for her background as an Oncologist and TCM doctor who also identified as a nun of buddhism, and she is willing to cooperate with more medical scientist, scholars or Philosopher who have an interest in multidisciplinary field and willing to do something meaningful and beneficial to general public and patients.
簡采汝醫師在台灣成長並接受完整的教育，既是一位佛教比丘尼，也是一位血液腫瘤專科醫師。在完成總醫師訓練後出家為尼，同時持續投身於癌症照護的臨床工作。她致力於將佛教思想與臨床醫學相結合，並以整體照護的觀點陪伴癌症病人，關注他們的身體病痛與心靈需求。
簡醫師的獨特之處在於，她同時擁有中醫師資格，並多年來將中醫應用於癌症病患的治療實務中。目前她擔任國立陽明大學醫學院傳統醫學研究所的助理教授，致力於中醫在癌症照護中的整合應用。儘管目前在以西醫為主體的市立醫院服務，她仍投入大量時間於中醫臨床與研究。其動機源於她觀察到許多癌症病患因癌症相關症狀尋求中醫協助，卻常因與臨床醫師溝通困難而猶豫不決。她希望能協調這兩種醫療體系（文化），為病人帶來實質幫助與意義。
根據她的臨床經驗與研究結果，部分中醫療法確實具有改善癌症相關症狀、或提升化療療效且具安全性的潛力，這些療效的機制耐人尋味，有些與免疫刺激理論相符，仍需進一步研究驗證。簡醫師憑藉其腫瘤專科與中醫雙重背景，以及出家人身分，在整合醫學領域具有傑出的地位。她也樂意與更多在多元學科領域中有志之士──無論是醫學科學家、學者或哲學家──攜手合作，共同推動對社會大眾與病患有益且富有意義的工作。
台北市立聯合醫院內科部血液腫瘤科主治醫師
Dr. Tsai-Ju, Chien, grew up and received education in Taiwan, is a Buddhism Nun as well as a Hema-Oncologist. She has devoted to be a nun after complete chief resident training and then still keep her career in cancer care. She is an idealism in connecting the Buddhism and clinical medicine, and also experienced in cancer patient’s care from a holistic perspective, take care of their physical disease as well as spiritual care. The unique character of her is that she also possesses Traditional Chinese Medicine and has applied TCM in cancer patients for years. Dr. Chien is now as an assistant professor in Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, devoting her-self in integrating TCM in cancer care. Though she works in a western- medicine based City public hospital, she spends a lot time in TCM research and clinical practice. The reason is that she has observed so many cancer patients, who suffered from cancer- related symptom seeking for TCM help but hesitate to discuss with their clinical physicians, she wants to do something to coordinate these two branches of medicine (cultures) and meaningful to patients. Based on her clinical experience and research, some TCM indeed has the potential in improving symptoms related to cancer or enhancing efficiency of chemotherapy with confirmed safety. The mechanism is intriguing; some are compatible with immune stimulation theory yet need further study. Dr. Chien is pre-eminent in the field of Integrative Medicine for her background as an Oncologist and TCM doctor who also identified as a nun of buddhism, and she is willing to cooperate with more medical scientist, scholars or Philosopher who have an interest in multidisciplinary field and willing to do something meaningful and beneficial to general public and patients.
簡采汝醫師在台灣成長並接受完整的教育，既是一位佛教比丘尼，也是一位血液腫瘤專科醫師。在完成總醫師訓練後出家為尼，同時持續投身於癌症照護的臨床工作。她致力於將佛教思想與臨床醫學相結合，並以整體照護的觀點陪伴癌症病人，關注他們的身體病痛與心靈需求。
簡醫師的獨特之處在於，她同時擁有中醫師資格，並多年來將中醫應用於癌症病患的治療實務中。目前她擔任國立陽明大學醫學院傳統醫學研究所的助理教授，致力於中醫在癌症照護中的整合應用。儘管目前在以西醫為主體的市立醫院服務，她仍投入大量時間於中醫臨床與研究。其動機源於她觀察到許多癌症病患因癌症相關症狀尋求中醫協助，卻常因與臨床醫師溝通困難而猶豫不決。她希望能協調這兩種醫療體系（文化），為病人帶來實質幫助與意義。
根據她的臨床經驗與研究結果，部分中醫療法確實具有改善癌症相關症狀、或提升化療療效且具安全性的潛力，這些療效的機制耐人尋味，有些與免疫刺激理論相符，仍需進一步研究驗證。簡醫師憑藉其腫瘤專科與中醫雙重背景，以及出家人身分，在整合醫學領域具有傑出的地位。她也樂意與更多在多元學科領域中有志之士──無論是醫學科學家、學者或哲學家──攜手合作，共同推動對社會大眾與病患有益且富有意義的工作。
Rencheng Gao 高任騁
Co-founder and CEO of Gene Origin
極因造物聯合創始人兼CEO
Gao earned his Bachelor’s degree in Biotechnology from Peking University in 2010, with a minor in Philosophy. He began his career as a rural teacher and later participated in founding several technology companies and educational institutions, advocating for the organic integration of science, technology, and the humanities. He is currently the Co-founder and CEO of Gene Origin, dedicated to leveraging synthetic biology to improve models of human development.
高總於2010年在北京大學獲生物技術學士學位並輔修哲學。他從鄉村教師起步開啓職業生涯，曾參與創立多家科技公司與教育機構，倡導科技與人文的有機結合。現任極因造物聯合創始人兼CEO，致力於利用合成生物技術改善人類發展模式。
極因造物聯合創始人兼CEO
Gao earned his Bachelor’s degree in Biotechnology from Peking University in 2010, with a minor in Philosophy. He began his career as a rural teacher and later participated in founding several technology companies and educational institutions, advocating for the organic integration of science, technology, and the humanities. He is currently the Co-founder and CEO of Gene Origin, dedicated to leveraging synthetic biology to improve models of human development.
高總於2010年在北京大學獲生物技術學士學位並輔修哲學。他從鄉村教師起步開啓職業生涯，曾參與創立多家科技公司與教育機構，倡導科技與人文的有機結合。現任極因造物聯合創始人兼CEO，致力於利用合成生物技術改善人類發展模式。
Previous Forum Photos
 |  |  |
|---|---|---|
 |  |  |
bottom of page